CANNON JAMES ANTHONY 4
4 · ZIOPHARM ONCOLOGY INC · Filed Jan 2, 2019
Insider Transaction Report
Form 4
CANNON JAMES ANTHONY
Director
Transactions
- Tax Payment
Common Stock
2018-12-29$1.66/sh−4,315$7,163→ 383,050 total - Award
Stock Option (right to buy)
2018-12-31+126,700→ 126,700 totalExercise: $1.87Exp: 2028-12-31→ Common Stock (126,700 underlying)
Footnotes (2)
- [F1]Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants.
- [F2]126,700 options vest on 12/31/2019.